Rapport Therapeutics, Inc. (RAPP) insider trading

{
  "status": "OK",
  "results": [
    {
      "tickers": [
        "RAPP"
      ],
      "issuer_cik": "0002012593",
      "owner_cik": "0001830326",
      "accession_number": "0001193125-26-430397",
      "form_type": "4",
      "filing_date": "2026-10-23",
      "period_of_report": "2026-10-23",
      "issuer_name": "Rapport Therapeutics, Inc.",
      "issuer_trading_symbol": "RAPP",
      "owner_name": "Sanchez Ramiro",
      "is_director": true,
      "is_officer": false,
      "is_ten_percent_owner": false,
      "is_other": false,
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Stock",
      "transaction_timeliness": "O",
      "aff_10b5_one": false,
      "transaction_date": "2026-10-23",
      "transaction_code": "P",
      "equity_swap_involved": false,
      "transaction_shares": 3600,
      "transaction_price_per_share": 27.3549,
      "transaction_acquired_disposed": "A",
      "shares_owned_following_transaction": 3600,
      "transaction_value": 98477.64,
      "direct_or_indirect": "D",
      "footnotes": [
        {
          "id": "F1",
          "description": "The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $27.07 to $27.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price at which the transactions were effected."
        }
      ]
    },
    {
      "tickers": [
        "RAPP"
      ],
      "issuer_cik": "0002012593",
      "owner_cik": "0001722140",
      "accession_number": "0001193125-26-430504",
      "form_type": "4",
      "filing_date": "2026-10-23",
      "period_of_report": "2026-10-21",
      "issuer_name": "Rapport Therapeutics, Inc.",
      "issuer_trading_symbol": "RAPP",
      "owner_name": "Ceesay Abraham",
      "is_director": true,
      "is_officer": true,
      "is_ten_percent_owner": false,
      "is_other": false,
      "officer_title": "Chief Executive Officer",
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Stock",
      "transaction_timeliness": "O",
      "aff_10b5_one": true,
      "transaction_date": "2026-10-21",
      "transaction_code": "S",
      "equity_swap_involved": false,
      "transaction_shares": 2210,
      "transaction_price_per_share": 29.1618,
      "transaction_acquired_disposed": "D",
      "shares_owned_following_transaction": 450035,
      "transaction_value": 64447.578,
      "direct_or_indirect": "D",
      "footnotes": [
        {
          "id": "F1",
          "description": "These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on March 27, 2026."
        },
        {
          "id": "F2",
          "description": "The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.89 to $29.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."
        }
      ]
    }
  ]
}

// trimmed to 2 results

The response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.